BRNS vs HSY · $38.2M cap vs P/E 36, rev $5.89B
Barinthus Biotherapeutics plc (BRNS) versus Hershey Co (HSY) — a side-by-side from cached financials, not a winner call.
Barinthus Biotherapeutics plc (BRNS) is a biotechnology company listed on US.
Hershey Co (HSY) is a confectioners company listed on US.
Latest reported BRNS revenue for 2025-09-30 was $0. Net income was -$14.6M. BRNS currently screens at market cap $38.2M.
Latest reported HSY revenue for 2026-06-28 was $5.89B. Net income was $892.8M. Revenue was up 89.8% from 2026-03-29 to 2026-06-28. HSY currently screens at market cap $39.36B and trailing P/E 36.1.
BRNS currently screens at market cap $38.2M. HSY currently screens at market cap $39.36B and trailing P/E 36.1.
Not investment advice. Open the BRNS and HSY stock pages for the full models.
Not investment advice.